For patients with the most common form of hepatitis C, the addition of a hepatitis C–specific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances of being cured, and it does it in half the time of standard therapy alone.

As many as half of all men taking the antidepressant medication paroxetine (trade names Seroxat, Paxil) may have increased sperm DNA fragmentation — a predictor of compromised fertility. Research led by NewYork-Presbyterian Hospital/Weill Cornell Medical Center also found that the changes are reversible with normal levels of sperm returning after discontinuation of the drug.

The Center for Digestive Care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has been established with a mission to provide high-quality patient care, research and education for all aspects of digestive disease. It offers innovative treatments and coordinated care for conditions ranging from gastrointestinal reflux and hepatitis C to colon cancer and metabolic surgery, a new field that focuses on reversing Type 2 diabetes.

Why do so many diets start successfully, only to crash and burn? Why is it that no matter how hard dieters try, keeping the weight off seems impossible? Dr. Louis Aronne explains that the key is your body's chemistry, not willpower. His solution: teaching your body to stop craving food and feel full sooner.

Dr. Herbert Pardes, President and Chief Executive Officer of NewYork-Presbyterian Hospital, discussed caring for the uninsured on the National Public Radio program "The Takeaway" on July 8, 2009.

A 7-year-old girl from Long Island, NY, is on her way home a little more than four weeks after receiving a historic surgery that involved the removal and partial re-implantation of six organs in order to resect an abdominal tumor that otherwise would be inoperable. The 23-hour surgery, which began on Feb. 6, was led by Dr. Tomoaki Kato at Morgan Stanley Children's Hospital of NewYork-Presbyterian, and is the first reported pediatric case of its kind.

Physician-scientists from NewYork-Presbyterian Hospital/Weill Cornell Medical Center believe that a heightened level a certain growth factor in the blood may explain why blacks have a greater prevalence of hypertension and kidney disease compared to whites. Results from a new study are the first to show that an elevated level of a protein, called transforming growth factor ß1 (TGF-ß1), raises the risk of hypertension and renal disease in humans.

Patients suffering from a blood disorder that prevents proper clotting have the option of a new medication that may dramatically improve their health. There are estimated to be between 50,000 and 100,000 individuals in the U.S. diagnosed with chronic immune thrombocytopenic purpura (ITP), an autoimmune disease that dramatically reduces the number of platelets in their blood — causing bruises, nosebleeds and, rarely, life-threatening brain hemorrhages